Close Menu

NEW YORK (GenomeWeb) – CooperSurgical is exiting its genetic carrier screening and noninvasive prenatal testing business, the firm said in a regulatory filing on Friday.

CooperGenomics, a unit of CooperSurgical, itself part of the Cooper Companies, had been offering a carrier screening test called CarrierMap, which tested for more than 300 genetic conditions, as well as an NIPT called ChromoMap, which tested for fetal trisomies 21, 18, and 13 and, optionally, a number of sex chromosome aneuploidies and microdeletions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.